Literature DB >> 12681953

Changes in subchondral bone in cartilage resurfacing--an experimental study in sheep using different types of osteochondral grafts.

B von Rechenberg1, M K Akens, D Nadler, P Bittmann, K Zlinszky, A Kutter, A R Poole, J A Auer.   

Abstract

OBJECTIVE: This article addresses the subchondral bone integrity in cartilage resurfacing by comparing fresh, untreated auto-, xeno-, and photooxidized osteochondral allo- and xenografts. Photooxidation was expected to improve mechanical stability of the osteochondral grafts through an improved linkage of the collagen fibers within the bone matrix.
DESIGN: Untreated auto- and xenografts and with photooxidation pretreated allo- and xenografts were surgically implanted in femoral condyles of sheep (n=40). After 2, 6, 12 and 18 months results were evaluated histologically using non-decalcified bone embedded in acrylic resin. Qualitative evaluation was performed with emphasis on bone matrix, biomechanical stability of graft anchorage, formation of cystic lesions, and bone resorption and formation. Quantitative evaluation of the total subchondral bone area was conducted histomorphometrically. Statistical analysis (factorial ANOVA test) was used to compare differences between groups with respect to the percentage of bone matrix and fibrous tissue per section.
RESULTS: Subchondral bone resorption was fastest in untreated, fresh autografts, followed by photooxidized allografts, untreated, fresh xenografts and last pretreated photooxidized xenografts. Cystic lesions were seen in all types of grafts, but were most pronounced at 6 months in autografts and least in photooxidized grafts. Cyst-like lesions had subsided substantially in the untreated auto- and photooxidized xenografts, if no graft dislocation occurred during the healing period. Mononuclear cell infiltration and an increase in the presence of multinuclear cells were observed at 2 months, mostly in untreated autografts, followed by photooxidized allo- and untreated xenografts. They were much higher in numbers compared to photooxidized grafts, at least in the early specimens at 2 months. Graft stability was linked to the rate of bone resorption.
CONCLUSION: Substantial resorption of the subchondral bone, involving the development of cyst-like lesions, lead to dislocation and finally to cartilage matrix degradation of the grafts. The process of photooxidation decreased the speed of bone resorption in osteochondral grafts and, thus, improved graft stability and cartilage survival. These results suggest that the remodeling of the subchondral bone of the host and the graft within the first 6 months is an important factor in graft stability and overall results of cartilage resurfacing.

Entities:  

Mesh:

Year:  2003        PMID: 12681953     DOI: 10.1016/s1063-4584(03)00006-2

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  31 in total

1.  Chondral Delamination of Fresh Osteochondral Allografts after Implantation in the Knee: A Matched Cohort Analysis.

Authors:  Ryan C Rauck; Dean Wang; Matthew Tao; Riley J Williams
Journal:  Cartilage       Date:  2018-05-23       Impact factor: 4.634

2.  CaAlg hydrogel containing bone morphogenetic protein 4-enhanced adipose-derived stem cells combined with osteochondral mosaicplasty facilitated the repair of large osteochondral defects.

Authors:  Linxin Chen; Yuanyuan Shi; Xin Zhang; Xiaoqing Hu; Zhenxing Shao; Linghui Dai; Xiaodong Ju; Yingfang Ao; Jianquan Wang
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-03-28       Impact factor: 4.342

3.  Influence of basal support and early loading on bone cartilage healing in press-fitted osteochondral autografts.

Authors:  Tomasz L Nosewicz; Mikel L Reilingh; Martin Wolny; C Niek van Dijk; Georg N Duda; Hanna Schell
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-12       Impact factor: 4.342

4.  Bone cysts after osteochondral allograft repair of cartilage defects in goats suggest abnormal interaction between subchondral bone and overlying synovial joint tissues.

Authors:  Andrea L Pallante-Kichura; Esther Cory; William D Bugbee; Robert L Sah
Journal:  Bone       Date:  2013-08-16       Impact factor: 4.398

5.  Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering.

Authors:  Jiehong Liao; Xuan Guo; K Jane Grande-Allen; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomaterials       Date:  2010-08-24       Impact factor: 12.479

6.  Long term results after implantation of tissue engineered cartilage for the treatment of osteochondral lesions in a minipig model.

Authors:  J P Petersen; P Ueblacker; C Goepfert; P Adamietz; K Baumbach; A Stork; J M Rueger; R Poertner; M Amling; N M Meenen
Journal:  J Mater Sci Mater Med       Date:  2007-10-24       Impact factor: 3.896

7.  Extraction techniques for the decellularization of tissue engineered articular cartilage constructs.

Authors:  Benjamin D Elder; Sriram V Eleswarapu; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2009-04-23       Impact factor: 12.479

8.  Rapid prototyping of anatomically shaped, tissue-engineered implants for restoring congruent articulating surfaces in small joints.

Authors:  T B F Woodfield; M Guggenheim; B von Rechenberg; J Riesle; C A van Blitterswijk; V Wedler
Journal:  Cell Prolif       Date:  2009-05-22       Impact factor: 6.831

Review 9.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

10.  Nondestructive Assessment of Articular Cartilage Electromechanical Properties after Osteochondral Autologous and Allogeneic Transplantation in a Goat Model.

Authors:  Tomas Mickevicius; Alius Pockevicius; Audrius Kucinskas; Rimtautas Gudas; Justinas Maciulaitis; Arvydas Usas
Journal:  Cartilage       Date:  2018-07-12       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.